| Recruiting | Cancer Loyalty Card Study 2 (CLOCS-2) NCT06447064 | Imperial College London | — |
| Recruiting | DESTINY-PANTUMOUR04 NCT07124000 | AstraZeneca | — |
| Not Yet Recruiting | Near-Infrared Fluorescence Imaging With Indocyanine Green to Evaluate Bowel Anastomoses in Gynecologic Oncolog NCT06871787 | Istanbul University | Phase 4 |
| Recruiting | E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers NCT05639972 | Christian Hinrichs | Phase 1 / Phase 2 |
| Recruiting | Belzutifan in Recurrent Clear Cell Carcinoma of Gynecologic Origin NCT06677190 | Dana-Farber Cancer Institute | Phase 2 |
| Recruiting | STRatIfication of Vulvar Squamous Cell Carcinoma by HPV and p53 Status to Guide Excision NCT05576831 | British Columbia Cancer Agency | N/A |
| Completed | Enhanced Assistance During Radiotherapy for Unmet Essential Needs NCT06582849 | Washington University School of Medicine | N/A |
| Not Yet Recruiting | UNDERSTANDING the RAREST GYNECOLOGICAL CANCERS: a MULTI -OMICS PLATFORM for IMPROVED PATIENTS MANAGEMENT NCT06582108 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | — |
| Recruiting | Danish Vulva Cancer Recurrence Study NCT06495554 | University of Aarhus | N/A |
| Recruiting | ASk Questions in GYnecologic Oncology (ASQ-GYO) NCT06339827 | Ira Winer | N/A |
| Recruiting | A Three-arm Randomized Phase II Study of Dostarlimab Alone or With Bevacizumab Versus Nonplatinum Chemotherapy NCT06023862 | Yonsei University | Phase 2 |
| Unknown | Vulvar Cancer Individualized Scoring System (VCISS) NCT06007625 | Assiut University | — |
| Active Not Recruiting | Study of Near-Infrared Imaging With Indocyanine Green for Detection of Sentinel Lymph Nodes in People With Vul NCT06127836 | Memorial Sloan Kettering Cancer Center | N/A |
| Recruiting | Using Reiki Therapy to Improve Symptoms Associated With Brachytherapy in Patients With Gynecological Malignanc NCT05979610 | University of Utah | Phase 2 |
| Recruiting | Indocyanine Green for Detection of Sentinel Lymph Nodes In Comparison to ICG Plus Technetium in the Evaluation NCT06039111 | Hamilton Health Sciences Corporation | — |
| Recruiting | Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment) NCT05743517 | Northwestern University | N/A |
| Recruiting | Immunotherapy-related CRP Kinetics in Metastatic Gynecological Malignancies NCT05914974 | University Hospital Tuebingen | — |
| Recruiting | AK104 for Recurrent or Metastatic Vulvar Cancer NCT05932212 | Akeso | Phase 2 |
| Completed | Study of a Rapid Triadic Communication Intention Elicitation Intervention to Improve Supportive Oncology Care NCT05995860 | Indiana University | N/A |
| Active Not Recruiting | Long-term Follow-up of Bivalent Human Papillomavirus (HPV) Vaccine Study in Women NCT06776055 | Shanghai Zerun Biotechnology Co.,Ltd | — |
| Recruiting | Optical Guided Sentinel Node Biopsy for Staging of Vulvar Cancer (I) NCT06029504 | Rigshospitalet, Denmark | — |
| Recruiting | NYSCF Scientific Discovery Biobank NCT06203106 | New York Stem Cell Foundation Research Institute | — |
| Unknown | Gynaecology Exercise and Mindfulness Study NCT05561413 | University of Ulster | N/A |
| Completed | Interventions to Decrease Financial Toxicity NCT05939440 | University of Alabama at Birmingham | N/A |
| Recruiting | Electrochemotherapy With Carboplatinum Plus Bleomycin Versus Bleomycin Alone in Vulvar Cancer NCT05395962 | IRCCS Azienda Ospedaliero-Universitaria di Bologna | Phase 2 |
| Unknown | MRI and Magnetometer-guided Sentinel Lymph Node Detection in Vulvar Cancer NCT06273501 | Sahlgrenska University Hospital | N/A |
| Completed | Clinical Implementation of Surface-guided Radiation Therapy in Vulvar Cancer NCT05853549 | Peking Union Medical College Hospital | N/A |
| Recruiting | Retrospective Study of Brachytherapy NCT05242861 | Zhejiang Cancer Hospital | — |
| Completed | Survey on Lymphedema After Sentinel Lymph Node Biopsy in People With Cervical or Vulvar Cancer NCT05255393 | Memorial Sloan Kettering Cancer Center | — |
| Suspended | Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types NCT05000294 | University of Florida | Phase 1 / Phase 2 |
| Completed | Early Detection of Vulval CAncer Through Self-Examination (EDuCATE): Intervention Study NCT04952961 | University of Manchester | N/A |
| Active Not Recruiting | A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Sm NCT04708470 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Recruiting | Electrochemotherapy for Recurrent Vulvar Cancer NCT07443475 | Institute of Oncology Ljubljana | Phase 2 |
| Recruiting | Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Year NCT04895020 | Shanghai Bovax Biotechnology Co., Ltd. | Phase 3 |
| Completed | The Registry of Oncology Outcomes Associated With Testing and Treatment NCT04028479 | Taproot Health | — |
| Unknown | Education, Immigration and HPV Vaccination: an Informational Randomized Trial NCT04905030 | Karolinska Institutet | N/A |
| Unknown | Electrochemotherapy for the Treatment of Vulvar Cancer NCT05916690 | Institute of Oncology Ljubljana | N/A |
| Recruiting | Screening for Anal Cancer in Women With High-grade Vulvar Dysplasia or Vulvar Cancer. NCT03061435 | Dr. Danielle Vicus | N/A |
| Recruiting | Groningen International Study on Sentinel Nodes in Vulvar Cancer-III NCT05076942 | University Medical Center Groningen | Phase 2 |
| Completed | Relational Agents in Cervical Cancer Education (RACE) NCT06537687 | Radhika Gogoi | N/A |
| Active Not Recruiting | A Multilevel Intervention to Improve Timely Cancer Detection and Treatment Initiation NCT04141449 | Brigham and Women's Hospital | Phase 2 |
| Completed | Efficacy of Immunotherapy Plus a Drug in Patients With Progressive Advanced Mucosal Cancer of Different Locati NCT04357873 | UNICANCER | Phase 2 |
| Completed | Evaluate the Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females NCT05372016 | Shanghai Bovax Biotechnology Co., Ltd. | Phase 3 |
| Active Not Recruiting | Cisplatin+Pembrolizumab+RT in Vulvar Cancer NCT04430699 | Massachusetts General Hospital | Phase 2 |
| Unknown | Indocyanine Green Fluorescence Imaging, Sentinel Lymph Node Mapping in Patients With Vulvar Cancer NCT04663412 | Azienda Ospedaliera per l'Emergenza Canizzaro | N/A |
| Completed | Evaluate the Immunogenicity and Safety of 4-valent and 9-valent HPV Recombinant Vaccine in Chinese Healthy Fem NCT04425291 | Shanghai Bovax Biotechnology Co., Ltd. | Phase 3 |
| Recruiting | Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Female NCT04422366 | Shanghai Bovax Biotechnology Co., Ltd. | Phase 3 |
| Recruiting | Serial MRI Scans During Radiation Therapy NCT04188535 | Dana-Farber Cancer Institute | N/A |
| Completed | The Lifestyle and Empowerment Techniques in Survivorship of Gynecologic Oncology Study NCT04122235 | Sorlandet Hospital HF | N/A |
| Suspended | Paclitaxel Therapeutic Drug Monitoring in Cancer Patients NCT03987555 | Wake Forest University Health Sciences | — |
| Active Not Recruiting | Quality of Life, Unmet Needs and Satisfaction With Care After Vulvar Cancer NCT04152512 | Karolinska University Hospital | — |
| Terminated | OCT-AF Imaging of Pre-cancers of Vulva and Cervix NCT03285841 | British Columbia Cancer Agency | — |
| Completed | Evaluate the Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females NCT03676101 | Shanghai Bovax Biotechnology Co., Ltd. | Phase 1 |
| Completed | Integrating a Health Information Technology System for Primary and Secondary Cervical Cancer Prevention NCT03346915 | Boston Medical Center | N/A |
| Active Not Recruiting | Intratreatment FDG-PET During Radiation Therapy for Gynecologic and Gastrointestinal Cancers NCT03403465 | Duke University | Phase 2 |
| Completed | Immunogenicity and Tolerability of Broad Spectrum Human Papillomavirus (HPV) Vaccine in Adult and Young Adult NCT03158220 | Merck Sharp & Dohme LLC | Phase 3 |
| Completed | CaptHPV : Validation of the Method "CaptHPV" for the Diagnosis of Human Papillomavirus Associated Infiltrating NCT02981862 | Institut de Cancérologie de Lorraine | N/A |
| Recruiting | Image-Guided Gynecologic Brachytherapy NCT02993900 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | N/A |
| Unknown | Ultrasound Morphometric and Cyto/Histological Combined Pre-operative Assessment of Inguinal Lymph Node Status NCT02988765 | Catholic University of the Sacred Heart | N/A |
| Unknown | HORIZONS: Understanding the Impact of Cancer Diagnosis and Treatment on Everyday Life NCT03000192 | University Hospital Southampton NHS Foundation Trust | — |
| Completed | MR-HIFU for Recurrent Gynaecological Cancer NCT02714621 | Institute of Cancer Research, United Kingdom | N/A |
| Active Not Recruiting | Long-term Follow-up of Broad Spectrum Human Papillomavirus (HPV) Vaccine Study in Women (V503-021) NCT02653118 | Merck Sharp & Dohme LLC | — |
| Active Not Recruiting | Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158) NCT02628067 | Merck Sharp & Dohme LLC | Phase 2 |
| Completed | Scripted Sexual Health Informational Intervention in Improving Sexual Function in Patients With Gynecologic Ca NCT02096783 | University of Wisconsin, Madison | N/A |
| Completed | The Impact of the "WOMAN-PRO II Program" on Patients With Vulvar Neoplasia to Minimize Post-surgical Symptom P NCT01986725 | St.Gallen University of Applied Sciences | Phase 2 |
| Unknown | Groin Sentinel Node Biopsy and 18FDG-PET/CT in cN0 Vulvar Cancer Patients Candidate to Standard Lymphadenectom NCT02969278 | Catholic University of the Sacred Heart | N/A |
| Terminated | Study to Evaluate the Role of PlasmaJet in Patients Undergoing Groin Node Dissection for Vulval Cancer NCT04105465 | Royal Surrey County Hospital NHS Foundation Trust | N/A |
| Completed | A Survivorship Care Plan for Gynaecological Cancer Patients NCT01582906 | Royal Marsden NHS Foundation Trust | — |
| Completed | Validation of a Nutrition Screening Tool NCT01851928 | Royal Marsden NHS Foundation Trust | — |
| Completed | Pelvic Floor Disorders in Survivors of Gynecologic Malignancies NCT01370122 | Abramson Cancer Center at Penn Medicine | — |
| Terminated | A Non-Randomized Study to Evaluate Leg Lymphatic Drainage Associated With Surgical Intervention for Vulvar Can NCT01321697 | University of Arkansas | — |
| Completed | Study of Physical and Psychosocial Rehabilitation Needs of Patients After Diagnosis and Treatment of Upper Gas NCT01216813 | Royal Marsden NHS Foundation Trust | — |
| Completed | Pelvic Floor Muscle Training in Treating Urinary Incontinence in Gynecologic Cancer Survivors NCT01806350 | New Mexico Cancer Research Alliance | N/A |
| Completed | A Study of V503 (A Multivalent Human Papillomavirus [HPV] L1 Virus-Like Particle [VLP] Vaccine) in Preadolesce NCT00943722 | Merck Sharp & Dohme LLC | Phase 3 |
| Completed | Videoscopic Versus Open Inguinal Lymphadenectomy for Cancer NCT01526486 | Emory University | N/A |
| Completed | Outcomes From Home in Patients Recovering From Major Gynecologic Cancer Surgery: Measuring Symptoms and Health NCT00870233 | Memorial Sloan Kettering Cancer Center | — |
| Completed | Topotecan in Treating Patients With Gynecologic Cancer That Cannot Be Removed by Surgery NCT00842452 | Steven Waggoner, MD | Phase 1 |
| Unknown | Nutritional Supplements in Improving Quality of Life During First-Line Chemotherapy in Patients With Metastati NCT00905658 | Centre Oscar Lambret | Phase 2 |
| Completed | Added-value of SPECT/CT in Patients Undergoing LM/SL for Gynecological Cancers NCT00773071 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | N/A |
| Completed | Broad Spectrum HPV (Human Papillomavirus) Vaccine in 16 to 26 Year Old Women (V505-001) NCT00520598 | Merck Sharp & Dohme LLC | Phase 2 |
| Completed | A Study to Evaluate Tolerability and Immunogenicity of V504 Administered Concomitantly With GARDASIL (V504-001 NCT00551187 | Merck Sharp & Dohme LLC | Phase 2 |
| Completed | Broad Spectrum HPV (Human Papillomavirus) Vaccine Study in 16-to 26-Year-Old Women (V503-001) NCT00543543 | Merck Sharp & Dohme LLC | Phase 3 |
| Completed | Topical Imiquimod in Treating Patients With Recurrent Paget's Disease of the Vulva NCT00504023 | Memorial Sloan Kettering Cancer Center | N/A |
| Completed | Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer NCT00381888 | Masonic Cancer Center, University of Minnesota | Phase 2 |
| Terminated | ChemoFx® PRO - A Post-Market Data Collection Study NCT00669422 | Precision Therapeutics | — |
| Completed | Broad Spectrum HPV Vaccine Dose Escalation Study (V502-002) NCT00851643 | Merck Sharp & Dohme LLC | Phase 1 |
| Unknown | Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Brea NCT00601406 | The Christie NHS Foundation Trust | N/A |
| Terminated | Chemoradiation-Induced Nausea and Emesis: Quality of Life NCT00394602 | M.D. Anderson Cancer Center | — |
| Completed | Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic Cancer NCT00287885 | Masonic Cancer Center, University of Minnesota | Phase 1 |
| Completed | Conservative Management With Isolated Sentinel Lymph Node Biopsy in Vulvar Cancer Patients. NCT00315159 | Women and Infants Hospital of Rhode Island | N/A |
| Completed | Effectiveness of an Individualized Symptom Education Program (ISEP) NCT00275353 | University of Toronto | Phase 2 |
| Completed | Fibrin Sealant in Decreasing Lymphedema Following Surgery to Remove Lymph Nodes in Patients With Cancer of the NCT00028951 | Gynecologic Oncology Group | Phase 3 |
| Completed | Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis NCT00033605 | Alliance for Clinical Trials in Oncology | Phase 3 |
| Terminated | Radiation Therapy With or Without Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Cancer o NCT00006096 | Gynecologic Oncology Group | Phase 3 |
| Completed | Paclitaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Cancer of the Vulva NCT00014599 | European Organisation for Research and Treatment of Cancer - EORTC | Phase 2 |
| Recruiting | Specimen and Data Study for Ovarian Cancer Early Detection and Prevention NCT00005095 | Northwestern University | — |
| Completed | Lymphatic Mapping in Treating Patients With Stage I or Stage II Cancer of the Vulva NCT00003325 | Gynecologic Oncology Group | Phase 3 |
| Completed | Vaccine Therapy in Treating Patients With Advanced or Recurrent Cancer NCT00019110 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Radiation Therapy or Surgery in Treating Patients With Previously Untreated Vulva Cancer With Positive Groin L NCT00898352 | Gynecologic Oncology Group | Phase 3 |
| Withdrawn | Chemoprevention of Cancer in the Lower Female Genital Tract: The Antineoplastic Activity of the Fungicide Cicl NCT00382330 | University of Medicine and Dentistry of New Jersey | N/A |